2. Antibody-drug Conjugate/ADC Related
  3. Drug-Linker Conjugates for ADC
  4. 2114651-20-4

2114651-20-4

β-Lactamase-IN-2 Chemical Structure

2114651-20-4

Chemical Structure

  • β-Lactamase-IN-2
  • Synonym(s): EX-A4764; UUN51204
  • CAS No: 2114651-20-4
    Formula: C11H9FO3
    Molecular Weight: 208.19
  • IUPAC Name: ethyl 6-fluorobenzofuran-7-carboxylate
  • InChIKey: UCYZLXGEGADIQQ-UHFFFAOYSA-N
  • SMILES: O=C(C1=C(OC=C2)C2=CC=C1F)OCC

Biological Activity: β-Lactamase-IN-2 is a beta-lactamase inhibitor, extracted from patent WO 2019075084 A1, compound 1. β-Lactamase-IN-2 has anti-microbial and anti-bacterial effects[1].

Cat. No. Product Name Purity Description
HY-138247R β-Lactamase-IN-2 (Standard) ATP (disodium salt) (Standard) is the analytical standard of ATP (disodium salt). This product is intended for research and analytical applications. ATP disodium salt (Adenosine 5'-triphosphate disodium salt) is a central component of energy storage and metabolism in vivo, provides the metabolic energy to drive metabolic pumps and serves as a coenzyme in cells. ATP disodium salt is an important endogenous signaling molecule in immunity and inflammation.
HY-138247 β-Lactamase-IN-2 98.59% β-Lactamase-IN-2 is a beta-lactamase inhibitor, extracted from patent WO 2019075084 A1, compound 1. β-Lactamase-IN-2 has anti-microbial and anti-bacterial effects.

References

[1]. Scott J. Hecker, et al. Boronic acid derivatives and synthesis thereof. Patent WO 2019075084

Keywords:

β-Lactamase-IN-2 (Standard)β-Lactamase-IN-2